Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-25-001257

← back to feed
Filed
Jul 22, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q1 2024 · Mar 31, 2024 $297.78K
Current Liabilities Q1 2024 · Dec 31, 2023 $288.58K
Total Liabilities Q1 2024 · Mar 31, 2024 $318.1K
Total Liabilities Q1 2024 · Dec 31, 2023 $315.47K
Current Assets Q1 2024 · Mar 31, 2024 $151
Current Assets Q1 2024 · Dec 31, 2023 $1.63K
Total Assets Q1 2024 · Mar 31, 2024 $50.79K
Total Assets Q1 2024 · Dec 31, 2023 $58.46K
Rd Expense Q1 2024 · Mar 31, 2024 $0
Rd Expense Q1 2024 · Mar 31, 2023 $2.52M
Shares Diluted Q1 2024 · Mar 31, 2023 60.04M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$5.57K
Stockholders Equity Q1 2024 · Mar 31, 2023 $410.9K
Stockholders Equity Q1 2024 · Dec 31, 2022 $486.37K
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.07
Sga Expense Q1 2024 · Mar 31, 2023 $1.48M
Net Income Q1 2024 · Mar 31, 2023 −$4M
Operating Income Q1 2024 · Mar 31, 2023 −$4M
Revenue Q1 2024 · Mar 31, 2023 $0